Evolent Health (STU:9EH) Additional Paid-In Capital : €1,661 Mil(As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evolent Health Additional Paid-In Capital?

Evolent Health's quarterly additional paid-in capital declined from Sep. 2023 (€1,690 Mil) to Dec. 2023 (€1,658 Mil) but then increased from Dec. 2023 (€1,658 Mil) to Mar. 2024 (€1,661 Mil).

Evolent Health's annual additional paid-in capital increased from Dec. 2021 (€1,187 Mil) to Dec. 2022 (€1,404 Mil) and increased from Dec. 2022 (€1,404 Mil) to Dec. 2023 (€1,658 Mil).

Evolent Health Additional Paid-In Capital Historical Data

The historical data trend for Evolent Health's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Additional Paid-In Capital Chart

Evolent Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,056.34

1,010.50

1,186.78

1,403.59

1,658.05

Evolent Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,652.25	1,638.13	1,689.52	1,658.05	1,661.23

Evolent Health Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Evolent Health Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Evolent Health's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health (STU:9EH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

EVH:USA

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Evolent Health (STU:9EH) Headlines

No Headlines